This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

HIV tests during the window period

Authoring team

HIV tests during the window period

British Association for Sexual Health and HIV (BASHH)/ /Expert Advisory Group on AIDS (EAGA) statement on HIV window period:

  • accredited diagnostic laboratories in the UK use "fourth generation " tests for HIV. These test for HIV antibodies and p24 antigen simultaneously in venous samples, and will detect the great majority of individuals who have been infected with HIV at 4 weeks after exposure

  • patients attending for HIV testing who identify a specific risk occurring less than 4 weeks previously should not be made to wait before HIV testing as doing so may miss an opportunity to diagnose HIV (in particular acute HIV infection during which a person is highly infectious). They should be offered a laboratory "fourth generation " HIV test on a venous sample and be advised to repeat it when 4 weeks have elapsed from the time of the last exposure

  • a negative result on a fourth generation test performed at 4 weeks post-exposure is highly likely to exclude HIV infection. A further test at 8 weeks need only be considered following an event assessed as carrying a high risk of infection

  • patients at ongoing risk of HIV infection should be advised to retest at regular intervals

  • patients should be advised to have tests for other sexually transmitted infections in line with advice on window periods for those infections (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.